Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Daix, May 21 2013 – Inventiva, a French biotech company specialized in drug discovery
partnerships in addition to developing its own proprietary pipeline, announced today that Dr.
Christian Montalbetti has joined the company and will be based at Inventiva’s research
center in Daix, near Dijon, France. As head of the chemistry department his responsibilities
will include managing the medicinal chemistry, analytical chemistry, CADD and parallel
Christian obtained his PhD at Université Pierre et Marie Curie. After completing his
postdoctoral fellowship at the University of Newcastle upon Tyne, he joined Evotec in 1998,
where he successfully led numerous medicinal chemistry projects in collaboration with major
pharmaceutical and biotechs companies, covering diverse therapeutic areas.
Dr Pierre Broqua, Co-Founder and Chief Scientific Officer of Inventiva, said: «Christian has
collaborated with a large number of pharmaceutical and biotech companies during his tenure
at Evotec. Inventiva will therefore benefit from his experience in setting up and managing
discovery partnerships in addition to his medicinal chemistry expertise. This recruitment
reflects our ongoing commitment to our partner’s success through the investment in the right
Inventiva is a drug-discovery company specializing in research partnerships with pharmaceutical firms
in diverse therapeutic areas such as Parkinson’s disease, immuno-inflammatory disorders, fibrosis
and cancer. Inventiva advances research programs to pre-clinical stage by leveraging its longstanding
expertise in nuclear receptors, transcription factors and epigenetics. With a research centre
based at Daix, near Dijon (France), Inventiva has more than 90 employees.
For more information on Inventiva, please visit the company’s website: www.inventivapharma.com
Frédéric Cren, CEO
Tel: + 33 (0)3 80 44 75 00
Tel: + 33 (0)1 53 96 83 83
Help employers find you! Check out all the jobs and post your resume.